Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309372 · ClinicalTrials.gov registry record · NA
Depression Therapy to Improve Cardiovascular Risk in HIV
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT02309372 is a NA study that has completed, run by Indiana University. The registered enrollment target is 54 participants.
The verdict
NCT02309372, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This trial will determine if depression treatment will reduce cardiovascular risk in HIV-infected patients already receiving HIV treatments. Half of the participants will undergo a specific computerized depression treatment with the other half receiving usual care from their HIV providers.
Interventions
- BEHAVIORAL Beating the Blues
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02309372
The ClinicalTrials.gov registry entry for NCT02309372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beating the Blues is the first listed.
NCT02309372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02309372 about?
NCT02309372 is a clinical study titled "Depression Therapy to Improve Cardiovascular Risk in HIV". This trial will determine if depression treatment will reduce cardiovascular risk in HIV-infected patients already receiving HIV treatments. Half of the participants will undergo a specific computerized depression treatment with the other half receiving usual care from their HIV providers.
What is the current status of trial NCT02309372?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2015-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02309372?
The interventions under investigation include: Beating the Blues (BEHAVIORAL).
Who is sponsoring clinical trial NCT02309372?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.